Michael T. Griffin

1.3k total citations
46 papers, 914 citations indexed

About

Michael T. Griffin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Animal Science and Zoology. According to data from OpenAlex, Michael T. Griffin has authored 46 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Cellular and Molecular Neuroscience and 6 papers in Animal Science and Zoology. Recurrent topics in Michael T. Griffin's work include Receptor Mechanisms and Signaling (25 papers), Neuropeptides and Animal Physiology (16 papers) and Pharmacological Effects and Assays (6 papers). Michael T. Griffin is often cited by papers focused on Receptor Mechanisms and Signaling (25 papers), Neuropeptides and Animal Physiology (16 papers) and Pharmacological Effects and Assays (6 papers). Michael T. Griffin collaborates with scholars based in United States, Japan and Canada. Michael T. Griffin's co-authors include Frederick J. Ehlert, Katherine W. Figueroa, Minoru Matsui, Makoto M. Taketo, Darakhshanda Shehnaz, David N. Ku, Gregory W. Sawyer, Ping‐Yee Law, Horace H. Loh and Alex K. Manda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Journal of Neurochemistry.

In The Last Decade

Michael T. Griffin

46 papers receiving 890 citations

Peers

Michael T. Griffin
Michael T. Griffin
Citations per year, relative to Michael T. Griffin Michael T. Griffin (= 1×) peers Tingting Du

Countries citing papers authored by Michael T. Griffin

Since Specialization
Citations

This map shows the geographic impact of Michael T. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Griffin more than expected).

Fields of papers citing papers by Michael T. Griffin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Griffin. The network helps show where Michael T. Griffin may publish in the future.

Co-authorship network of co-authors of Michael T. Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Griffin. A scholar is included among the top collaborators of Michael T. Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Griffin. Michael T. Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Griffin, Michael T., et al.. (2021). Negatively charged nanoparticles of multiple materials inhibit shear-induced platelet accumulation. Nanomedicine Nanotechnology Biology and Medicine. 35. 102405–102405. 2 indexed citations
2.
Griffin, Michael T., et al.. (2018). Inhibition of high shear arterial thrombosis by charged nanoparticles. Biomicrofluidics. 12(4). 42210–42210. 21 indexed citations
3.
Manda, Alex K., et al.. (2014). Evolution of multi-well pad development and influence of well pads on environmental violations and wastewater volumes in the Marcellus shale (USA). Journal of Environmental Management. 142. 36–45. 26 indexed citations
4.
Ehlert, Frederick J., Kirk J. Pak, & Michael T. Griffin. (2011). Muscarinic Agonists and Antagonists: Effects on Gastrointestinal Function. Handbook of experimental pharmacology. 343–374. 32 indexed citations
5.
Ehlert, Frederick J., et al.. (2011). Analysis of Agonism and Inverse Agonism in Functional Assays with Constitutive Activity: Estimation of Orthosteric Ligand Affinity Constants for Active and Inactive Receptor States. Journal of Pharmacology and Experimental Therapeutics. 338(2). 671–686. 23 indexed citations
6.
Ehlert, Frederick J., et al.. (2011). Analysis of Functional Responses at G Protein-Coupled Receptors: Estimation of Relative Affinity Constants for the Inactive Receptor State. Journal of Pharmacology and Experimental Therapeutics. 338(2). 658–670. 11 indexed citations
7.
Griffin, Michael T., Minoru Matsui, Rennolds S. Ostrom, & Frederick J. Ehlert. (2009). The guinea pig ileum lacks the direct, high-potency, M2-muscarinic, contractile mechanism characteristic of the mouse ileum. Naunyn-Schmiedeberg s Archives of Pharmacology. 380(4). 327–335. 8 indexed citations
8.
Ehlert, Frederick J. & Michael T. Griffin. (2008). Two-State Models and the Analysis of the Allosteric Effect of Gallamine at the M2 Muscarinic Receptor. Journal of Pharmacology and Experimental Therapeutics. 325(3). 1039–1060. 19 indexed citations
9.
Figueroa, Katherine W., Michael T. Griffin, & Frederick J. Ehlert. (2008). Selectivity of Agonists for the Active State of M1 to M4 Muscarinic Receptor Subtypes. Journal of Pharmacology and Experimental Therapeutics. 328(1). 331–342. 63 indexed citations
10.
Griffin, Michael T., et al.. (2007). Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15. Journal of Pharmacology and Experimental Therapeutics. 321(3). 1193–1207. 103 indexed citations
11.
Ehlert, Frederick J., et al.. (2005). The M2 Muscarinic Receptor Mediates Contraction through Indirect Mechanisms in Mouse Urinary Bladder. Journal of Pharmacology and Experimental Therapeutics. 313(1). 368–378. 69 indexed citations
12.
Griffin, Michael T., Minoru Matsui, Darakhshanda Shehnaz, et al.. (2004). Muscarinic Agonist-Mediated Heterologous Desensitization in Isolated Ileum Requires Activation of Both Muscarinic M2 and M3 Receptors. Journal of Pharmacology and Experimental Therapeutics. 308(1). 339–349. 18 indexed citations
13.
Matsui, Minoru, Michael T. Griffin, Darakhshanda Shehnaz, Makoto M. Taketo, & Frederick J. Ehlert. (2003). Increased Relaxant Action of Forskolin and Isoproterenol against Muscarinic Agonist-Induced Contractions in Smooth Muscle from M2 Receptor Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 305(1). 106–113. 56 indexed citations
14.
Griffin, Michael T., et al.. (2003). Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination. Biochemical Pharmacology. 65(8). 1227–1241. 19 indexed citations
15.
Shehnaz, Darakhshanda, et al.. (2001). Acetylcholine-mediated desensitization of histamine-induced contraction in the guinea pig ileum is prevented by pertussis toxin or by inactivation of muscarinic M3 receptors. Life Sciences. 68. 263827. 2 indexed citations
16.
Shehnaz, Darakhshanda, et al.. (2001). Acetylcholine-Induced Desensitization of Muscarinic Contractile Response in Guinea Pig Ileum Is Inhibited by Pertussis Toxin Treatment. Journal of Pharmacology and Experimental Therapeutics. 299(3). 1126–1132. 5 indexed citations
17.
Ehlert, Frederick J., et al.. (1999). A Simple Method for Estimation of Agonist Activity at Receptor Subtypes: Comparison of Native and Cloned M3 Muscarinic Receptors in Guinea Pig Ileum and Transfected Cells. Journal of Pharmacology and Experimental Therapeutics. 289(2). 981–992. 69 indexed citations
18.
Ehlert, Frederick J. & Michael T. Griffin. (1998). The use of irreversible ligands to inactivate receptor subtypes: 4-DAMP mustard and muscarinic receptors in smooth muscle. Life Sciences. 62(17-18). 1659–1664. 10 indexed citations
19.
Griffin, Michael T., et al.. (1996). Stimulation of cyclic AMP accumulation and phosphoinositide hydrolysis by M3 muscarinic receptors in the rat peripheral lung. Biochemical Pharmacology. 52(4). 643–658. 34 indexed citations
20.
Griffin, Michael T.. (1991). AIDS Drugs & the Pharmaceutical Industry: A Need For Reform. American Journal of Law & Medicine. 17(4). 363–410. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026